The star of Monday’s deal is gusacitinib, a small-molecule drug that Formation is developing for chronic hand eczema. Sanofi will explore additional indications for gusacitinib in a Phase I study.

Spiritual formation shouldn’t be an attempt to control ministry outcomes—it’s about cultivating space for God to work. This feature is only available to members. Join now for full online access. CT ...

EXCLUSIVE: Atlanta-based talent agency People Store has rebranded as Formation Talent Agency, brining in veteran agent Lauren Williams to serve as Senior Vice President of Talent amidst this evolution ...

It took just one game of the 2024 season to land NFL officiating back in the discourse. On the second play of Thursday night's game between the Kansas City Chiefs and Baltimore Ravens, referee Shawn ...

Formation Bio, a startup focused on applying AI to drug development with backing from OpenAI CEO Sam Altman, has raised over a quarter-billion dollars to support its ambitious product roadmap.

Megarounds have been few and far between in 2024, but Formation Bio has managed to draw in an impressive $372 million series D as the AI-focused biotech seeks to expand its pipeline. AI companies like ...

"Mass psychosis," "mass delusion," "mass formation psychosis," and "mass delusional psychosis" are terms being thrown around a lot lately to describe our ideological opposites. This is a pejorative ...

Cobalt Strike and Metasploit were the offensive security tools most commonly used to host malware command-and-control (C2) servers in 2020, researchers report. Researchers with Recorded Future's ...